Injectable BPC-157 for Injury Recovery and Targeted Support Subcutaneous injections are often considered the commonly used when higher systemic availability is desired
(US Patent 8598118) characterized hepatocyte growth factor mimics as therapeutic agents and established the mechanistic basis for Dihexas development
In contrast to injections, topical serums are cost-effective, practical, and have a good safety profile, in addition to providing potential benefits for hair and skin support
After six months of treatment, patients showed a significant increase in the number of hairs per square centimeter and an increase in hair thickness
First, BPC-157 promotes angiogenesis
DSIP is found in both free and protein-bound forms in the hypothalamus, limbic system, and pituitary gland, as well as in peripheral organs including the gut secretory cells, pancreas (where it co-localises with glucagon), and plasma with brain and plasma DSIP concentrations showing a marked diurnal variation that correlates with circadian rhythm in humans, with levels lowest in the morning and higher in the afternoon